A Phase 2 interventional study of Motivational Interviewing plus Incentives and Conventional Care (CC) in Exposure to Secondhand Smoke in Neonatal Infants, sponsored by The University of Texas Health Science Center, Houston. Completed at 1 site in United States. Per ClinicalTrials.gov, last updated 2018-05-14.
Sponsored by The University of Texas Health Science Center, Houston · Phase 2, Interventional, and Other
A randomized, controlled, parallel group design will be used to test whether a Secondhand Smoke Exposure program initiated in the hospital and completed in the home using motivational interviewing plus motivational incentives (MI+) is more effective than Conventional Care (CC) with Neonatal Incentives Care Unit Infants' parents.
The University of Texas Health Science Center, Houston is the lead sponsor of 880 studies on the registry; 209 are open to participants now.
Of its 170 completed or terminated interventional studies of FDA-regulated products, 140 (82%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Behavioral: Motivational Interviewing plus Incentives
Behavioral: Conventional Care (CC)
1. Two hospital-based, face-to-face MI+ sessions 2. Two home-based MI+ sessions 3. Attendance at each session and for the establishment of a household smoking ban at two timepoints post-discharge
Participants in this arm will receive brochures and a brief information meeting in the NICU.
Infant Second-Hand Smoke Exposure via Urine Cotinine
Infant Second-Hand Smoke Exposure (SHSe) measures will be determined via urine cotinine.
Time frame: Follow-up visit 4 months post-treatment
Secondhand Smoke Exposure outcomes
Primary caregiver reports via the Timeline Follow-Back and household air nicotine monitors. Number of cigarettes smoked outdoors vs. indoor and the implementation of household smoking bans will also be assessed. Primary caregivers will complete the SHSe related interviews and self-report questionnaires. Primary caregivers who are smokers will complete measures related to smoking and smoking cessation.
Time frame: Change from Baseline to the 4 months post-treatment followup
This study is completed, as verified in May 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
The University of Texas Health Science Center, Houston